Article info
PDFReview
Understanding biosimilars and its regulatory aspects across the globe: an ophthalmology perspective
- Correspondence to Dr Ashish Sharma, Vitreoretina, Lotus Eye Care Hospital, Coimbatore 641014, India; drashish79{at}hotmail.com
Citation
Understanding biosimilars and its regulatory aspects across the globe: an ophthalmology perspective
Publication history
- Received April 18, 2019
- Revised June 11, 2019
- Accepted June 26, 2019
- First published July 17, 2019.
Online issue publication
June 25, 2020
Article Versions
- Previous version (12 December 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.